HAPPENING NOW
The headlines, minus the noise. Updated in real time. Beta
PSA screening for prostate cancer reduces disease-specific deaths, new review shows
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review
AI Summary POWERED BY HAPPENING NOW AI
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review
Read full article →AI summaries can be wrong sometimes—always verify important details using the source link below.
Why this story matters
This story is being tracked across multiple sources, giving readers broader context as coverage develops.